Allen Bowling, MD, PhD
Check out articles by Allen Bowling, MD, PhD
Multiple sclerosis (MS) is a disease characterized by scarring of the central nervous system, but it is perceived very differently by clinicians, patients, researchers and others.
Hope on the Horizon: Oral Drugs and Barroom Brawls
"Five oral drugs for multiple sclerosis (MS) are currently in development. Read the article for an amusing but educational look at bodily ""barroom brawls"" and where ms drugs intervene."
Low Dose Naltrexone (LDN): Hope or Hype for MS Symptoms?
Low dose naltrexone arrived with much interest in the multiple sclerosis (MS) community, but it's understudied. Mandatory medication or worthless drug: what the experts are saying.
Statin Therapy and MS: What the Research Has Shown
Although promising in animal trials, cholesterol-lowering statins may interfere with the action of other drugs when used off-label to treat multiple sclerosis (MS) symptoms.
MS Research Update:The Great Debate--Inflammation vs Degeneration
Multiple sclerosis (MS) was long thought to be caused by inflammation of the central nervous system, but new information points to degeneration as well. News from the international MS conference.
Multiple sclerosis (MS) can be diagnosed and monitored with magnetic resonance imaging (MRI), but some patients become claustrophobic. Tips for making an MRI easier to get through.
Multiple sclerosis (MS) symptoms can mimic aging: loss of vision and decreased endurance and stability while walking. How can you tell which is which?
